Dorward, J., Sookrajh, Y., Lessells, R., Bulo, E., Bodley, N., Singh, L., . . . Garrett, N. (2024). Viremia and HIV drug resistance among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy. Lippincott, Williams & Wilkins.
Style de citation Chicago (17e éd.)Dorward, J., et al. Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-based First-line Antiretroviral Therapy. Lippincott, Williams & Wilkins, 2024.
Style de citation MLA (9e éd.)Dorward, J., et al. Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-based First-line Antiretroviral Therapy. Lippincott, Williams & Wilkins, 2024.
Attention : ces citations peuvent ne pas être correctes à 100%.